Skip to contentClarengateINTELLIGENCE
Companies/03247591

Oxford Gene Technology (Southern) Limited

Research and experimental development on biotechnology · Kidlington

ActiveUnited KingdomIncorporated 1996Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-03-31 · GBP · Company accounts

Net assets
−£5,398,143
Cash
£29,577
Turnover
—
Profit / loss
−£581
Current assets
£125,654
Creditors < 1 year
£5,523,797
Equity
−£5,398,143
Average employees
0

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

5 periods
Reported figures2025-03-31Company2024-03-31Company2023-04-01Company2023-03-312022-04-01
Balance sheet
Net assets−£5,398,143−£5,397,562−£5,397,148−£5,397,148—
Equity−£5,398,143−£5,397,562−£5,397,148−£5,397,148−£5,404,281
Assets
Current assets£125,654£118,131—£126,589—
Cash at bank£29,577£21,718—£30,176—
Liabilities
Creditors within one year£5,523,797£5,515,693—£5,523,737—
Net current assets−£5,398,143−£5,397,562—−£5,397,148—
Assets less current liabilities−£5,398,143−£5,397,562—−£5,397,148—
Profit & loss
Profit / loss−£581−£414—£7,133—
People
Average employees00—0—
Source evidenceView filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges
Show 1 satisfied / released
All Assets · created 2002-01-28 · satisfied 2009-01-21
All monies
Satisfied